Eric Chen VIEW CLINICAL PROFILE

Eric Chen, MD

Assistant Professor of Clinical Ophthalmology, Academic Institute
Houston Methodist
Weill Cornell Medical College


VIEW CLINICAL PROFILE
Education & Training

MD, Baylor College of Medicine
Clinical Fellowship, Wills Eye Institute
Internship, Austin Medical Education Program - Internship
Publications

MANAGEMENT OF LARGE FULL-THICKNESS MACULAR HOLES: Long-Term Outcomes of Internal Limiting Membrane Flaps and Internal Limiting Membrane Peels
Richards, K, Kadakia, A, Wykoff, CC, Major, JC, Wong, TP, Chen, E, Schefler, AC, Patel, SB, Kim, RY, Henry, CR, Fish, RH, Brown, DM, Benz, MS, Pearce, W & Shah, AR 2024, , Retina, vol. 44, no. 7, pp. 1165-1170. https://doi.org/10.1097/IAE.0000000000004099

Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Salabati, M, Huang, C, Kamalipour, A, Yu, HJ, Mahmoudzadeh, R, Jeng-Miller, K, Chen, E, Shah, CP, Wykoff, CC & Hsu, J 2024, , Ophthalmology Science, vol. 4, no. 2, 100372, pp. 100372. https://doi.org/10.1016/j.xops.2023.100372

Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
RECOVERY Study Group 2022, , Ophthalmology Retina, vol. 6, no. 7, pp. 557-566. https://doi.org/10.1016/j.oret.2022.02.013

The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections
Writing committee for the Post-Injection Endophthalmitis Study Group 2021, , Ophthalmology, vol. 128, no. 11, pp. 1620-1626. https://doi.org/10.1016/j.ophtha.2021.05.010

Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Hsu, J, Patel, SN, Wolfe, JD, Shah, CP, Chen, E, Jenkins, TL, Wibbelsman, TD, Obeid, A, Mikhail, M, Garg, SJ, Ho, AC, Chiang, A, Spirn, MJ & Vander, JF 2020, , JAMA Ophthalmology, vol. 138, no. 5, pp. 560-567. https://doi.org/10.1001/jamaophthalmol.2020.0724

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Study Group 2019, , Ophthalmology Retina, vol. 3, no. 12, pp. 1076-1086. https://doi.org/10.1016/j.oret.2019.07.011

Photocoagulation versus ranibizumab for proliferative diabetic retinopathy: Should Baseline Characteristics Affect Choice of Treatment?
Bressler, SB, Beaulieu, WT, Glassman, AR, Gross, JG, Melia, M, Chen, E, Pavlica, MR & Jampol, LM 2019, , Retina, vol. 39, no. 9, pp. 1646-1654. https://doi.org/10.1097/IAE.0000000000002377

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes
TREX-DME Study Group 2019, , American Journal of Ophthalmology, vol. 202, pp. 91-99. https://doi.org/10.1016/j.ajo.2019.02.005

The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab
Post-Injection Endophthalmitis (PIE) Study Group 2019, , American Journal of Ophthalmology, vol. 199, pp. 200-208. https://doi.org/10.1016/j.ajo.2018.11.023

Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial
TREX-AMD Study Group 2018, , American Journal of Ophthalmology, vol. 192, pp. 84-90. https://doi.org/10.1016/j.ajo.2018.05.008

Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications: Secondary outcomes from the SCORE2 randomized clinical trial
SCORE2 Investigator Group 2018, , JAMA Ophthalmology, vol. 136, no. 4, pp. 337-345. https://doi.org/10.1001/jamaophthalmol.2017.6843

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes
Diabetic Retinopathy Clinical Research Network 2018, , Ophthalmology, vol. 125, no. 11, pp. 1776-1783. https://doi.org/10.1016/j.ophtha.2018.04.039

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network 2018, , Ophthalmology, vol. 125, no. 7, pp. 1054-1063. https://doi.org/10.1016/j.ophtha.2018.01.019

Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial
Abdelfattah, NS, Al-Sheikh, M, Pitetta, S, Mousa, A, Sadda, SVR, Wykoff, CC, Wykoff, CC, Croft, DE, Brown, DM, Wang, R, Payne, JF, Clark, L, Sadda, SVR, Benz, MS, Chen, E, Fish, RH, Johnson, DL, Kim, RY, Major, JC, OMalley, RE, Schefler, AC, Shah, AR, Vance, SK, Wells, JA & Wong, TP 2017, , Ophthalmology, vol. 124, no. 2, pp. 215-223. https://doi.org/10.1016/j.ophtha.2016.10.002

Bilateral herpetic keratitis after bilateral intravitreal bevacizumab for exudative macular degeneration
Derham, AM, Chen, E, Bunya, VY & OMalley, RE 2017, , Cornea, vol. 36, no. 7, pp. 878-879. https://doi.org/10.1097/ICO.0000000000001233

The association of epiretinal membrane with macular hole formation after rhegmatogenous retinal detachment repair
Khurana, RN, Wykoff, CC, Bansal, AS, Akiyama, K, Palmer, JD, Chen, E, Chang, LK, Major, JC, Wu, C, Wang, R, Croft, DE & Wong, TP 2017, , Retina, vol. 37, no. 6, pp. 1073-1078. https://doi.org/10.1097/IAE.0000000000001307

Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept
Rayess, N, Rahimy, E, Storey, P, Shah, CP, Wolfe, JD, Chen, E, Decroos, FC, Garg, SJ & Hsu, J 2016, , American Journal of Ophthalmology, vol. 165, pp. 88-93. https://doi.org/10.1016/j.ajo.2016.02.028

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group 2016, , American Journal of Ophthalmology, vol. 164, pp. 29-36. https://doi.org/10.1016/j.ajo.2015.12.028

Endophthalmitis after intravitreal injection: Role of prophylactic topical ophthalmic antibiotics
Li, AL, Wykoff, CC, Wang, R, Chen, E, Benz, MS, Fish, RH, Wong, TP, Major, JC, Brown, DM, Schefler, AC, Kim, RY & Omalley, RE 2016, , Retina, vol. 36, no. 7, pp. 1349-1356. https://doi.org/10.1097/IAE.0000000000000901

Incidence and clinical features of post-injection endophthalmitis according to diagnosis
Rayess, N, Rahimy, E, Shah, CP, Wolfe, JD, Chen, E, De Croos, FC, Storey, P, Garg, SJ & Hsu, J 2016, , British Journal of Ophthalmology, vol. 100, no. 8, pp. 1058-1061. https://doi.org/10.1136/bjophthalmol-2015-307707

VIEW FULL PUBLICATIONS